CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.82+0.17 (+2.56%)
Close on Nov 18, 2026Market cap $341.32MP/E –Yield –
CapsoVision net income
Net income is the profit left for shareholders after every expense, interest and tax.
CapsoVision's net income for the twelve months ending Jun 30, 2026 was -$29.83M. For fiscal 2025 it was -$25.32M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.32M | – |
| FY2024 | Dec 31, 2024 | -$19.90M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.03M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.39M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.63M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.38M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.64M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.79M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.27M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.20M | – |
See a number that looks wrong?